Intraocular involvement of Mantle cell lymphoma: A case report and literature review

Madiha Iqbal, Yennifer Gil Castano, Taimur Sher, Mohamed A. Kharfan-Dabaja

Research output: Contribution to journalArticle

Abstract

Lymphomatous involvement of the ocular adnexal region (OAR) is generally rare; however, it constitutes the most common ocular malignancy. Most cases of ocular adnexal lymphomas are extra nodal marginal zone B cell lymphomas. Mantle cell lymphoma involvement (MCL) of the OAR is a less common presentation compared with other lymphomas and it has been reported anecdotally. Studies have suggested an association of OAR involvement with poor prognosis. Here, we report the case of a 61 year old man who started experiencing conjunctival erythema which was followed by development of bilateral proptosis. The diagnosis of Stage IV Mantle cell lymphoma with OAR involvement was confirmed 5 months after patient onset of symptomatology. He underwent treatment with systemic chemotherapy, which was followed by high-dose chemotherapy and autologous hematopoietic cell transplant. He is currently day +100 from his transplant and is in complete remission. A review of the literature regarding ocular involvement of MCL is also summarized.

Original languageEnglish (US)
JournalHematology/ Oncology and Stem Cell Therapy
DOIs
StatePublished - Jan 1 2019

Fingerprint

Mantle-Cell Lymphoma
Lymphoma
Transplants
Drug Therapy
Marginal Zone B-Cell Lymphoma
Exophthalmos
Erythema

Keywords

  • Mantle cell lymphoma involvement
  • Ocular adnexal region

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Intraocular involvement of Mantle cell lymphoma : A case report and literature review. / Iqbal, Madiha; Castano, Yennifer Gil; Sher, Taimur; Kharfan-Dabaja, Mohamed A.

In: Hematology/ Oncology and Stem Cell Therapy, 01.01.2019.

Research output: Contribution to journalArticle

@article{7df7a397914d450992b99044fbb8c000,
title = "Intraocular involvement of Mantle cell lymphoma: A case report and literature review",
abstract = "Lymphomatous involvement of the ocular adnexal region (OAR) is generally rare; however, it constitutes the most common ocular malignancy. Most cases of ocular adnexal lymphomas are extra nodal marginal zone B cell lymphomas. Mantle cell lymphoma involvement (MCL) of the OAR is a less common presentation compared with other lymphomas and it has been reported anecdotally. Studies have suggested an association of OAR involvement with poor prognosis. Here, we report the case of a 61 year old man who started experiencing conjunctival erythema which was followed by development of bilateral proptosis. The diagnosis of Stage IV Mantle cell lymphoma with OAR involvement was confirmed 5 months after patient onset of symptomatology. He underwent treatment with systemic chemotherapy, which was followed by high-dose chemotherapy and autologous hematopoietic cell transplant. He is currently day +100 from his transplant and is in complete remission. A review of the literature regarding ocular involvement of MCL is also summarized.",
keywords = "Mantle cell lymphoma involvement, Ocular adnexal region",
author = "Madiha Iqbal and Castano, {Yennifer Gil} and Taimur Sher and Kharfan-Dabaja, {Mohamed A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.hemonc.2019.03.002",
language = "English (US)",
journal = "Hematology/ Oncology and Stem Cell Therapy",
issn = "1658-3876",
publisher = "King Faisal Specialist Hospital and Research Centre",

}

TY - JOUR

T1 - Intraocular involvement of Mantle cell lymphoma

T2 - A case report and literature review

AU - Iqbal, Madiha

AU - Castano, Yennifer Gil

AU - Sher, Taimur

AU - Kharfan-Dabaja, Mohamed A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Lymphomatous involvement of the ocular adnexal region (OAR) is generally rare; however, it constitutes the most common ocular malignancy. Most cases of ocular adnexal lymphomas are extra nodal marginal zone B cell lymphomas. Mantle cell lymphoma involvement (MCL) of the OAR is a less common presentation compared with other lymphomas and it has been reported anecdotally. Studies have suggested an association of OAR involvement with poor prognosis. Here, we report the case of a 61 year old man who started experiencing conjunctival erythema which was followed by development of bilateral proptosis. The diagnosis of Stage IV Mantle cell lymphoma with OAR involvement was confirmed 5 months after patient onset of symptomatology. He underwent treatment with systemic chemotherapy, which was followed by high-dose chemotherapy and autologous hematopoietic cell transplant. He is currently day +100 from his transplant and is in complete remission. A review of the literature regarding ocular involvement of MCL is also summarized.

AB - Lymphomatous involvement of the ocular adnexal region (OAR) is generally rare; however, it constitutes the most common ocular malignancy. Most cases of ocular adnexal lymphomas are extra nodal marginal zone B cell lymphomas. Mantle cell lymphoma involvement (MCL) of the OAR is a less common presentation compared with other lymphomas and it has been reported anecdotally. Studies have suggested an association of OAR involvement with poor prognosis. Here, we report the case of a 61 year old man who started experiencing conjunctival erythema which was followed by development of bilateral proptosis. The diagnosis of Stage IV Mantle cell lymphoma with OAR involvement was confirmed 5 months after patient onset of symptomatology. He underwent treatment with systemic chemotherapy, which was followed by high-dose chemotherapy and autologous hematopoietic cell transplant. He is currently day +100 from his transplant and is in complete remission. A review of the literature regarding ocular involvement of MCL is also summarized.

KW - Mantle cell lymphoma involvement

KW - Ocular adnexal region

UR - http://www.scopus.com/inward/record.url?scp=85064174698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064174698&partnerID=8YFLogxK

U2 - 10.1016/j.hemonc.2019.03.002

DO - 10.1016/j.hemonc.2019.03.002

M3 - Article

AN - SCOPUS:85064174698

JO - Hematology/ Oncology and Stem Cell Therapy

JF - Hematology/ Oncology and Stem Cell Therapy

SN - 1658-3876

ER -